Novel function of wild-type p53 in cancer cells

Dear All,

Cell Signal Unit (Yamamoto Unit) would like to inform you of a seminar by Dr. Rieko Ohki from National Cancer Center Research Institute.

------------------------------------------------------------------------------------------------------

Date: Wednesday, April 7, 2021

Time: 10:00-11:00

Venue: C209 (Level C, Center) or ZOOM

             ZOOM: https://oist.zoom.us/j/94970675714?pwd=cXVDNzZVRGV2RHhLYzRsRmVmL29jQT09

             Meeting ID: 949 7067 5714
             **If you need the passcode, please send e-mail to "yuki.nakagawa[at]oist.jp".

------------------------------------------------------------------------------------------------------

 
Speaker:

Dr. Rieko Ohki, National Cancer Center Research Institute

Title:
Novel function of wild-type p53 in cancer cells

Abstract:
The tumor suppressor gene p53 is the most frequently mutated gene in human cancers and plays a central role in the regulation of tumorigenesis.  p53 is a transcription factor involved in the regulation of apoptosis, cell cycle arrest, DNA repair, etc., via its ability to transactivate a network of target genes. Since its discovery in 1979, utmost efforts have been made by the researchers to uncover the functions of p53, but the whole picture of p53 function has not yet been elucidated. In this seminar, I will focus on the novel function of wild-type p53 in cancer cells.

Host:
Prof. Tadashi Yamamoto

We hope to see many of you at the seminar.

Best regards,

Yuki Nakagawa

Research Unit Administrator

Cell Signal Unit